The Core of Hemophilia Treatment: Replacing Missing Clotting Factor

The main treatment for hemophilia is factor replacement therapy—infusing the clotting factor your body doesn't make enough of. If you have hemophilia A, you receive factor VIII. If you have hemophilia B, you receive factor IX. These factors come from donated human blood plasma or are made in laboratories using recombinant DNA technology. The infusion goes into a vein, usually in your arm, and takes 15 to 30 minutes.

Factor replacement works because it restores your blood's ability to form clots. Without it, bleeding into joints, muscles, and organs can continue unchecked. With it, your clotting cascade can proceed normally. Most people with moderate to severe hemophilia use factor replacement either on a schedule to prevent bleeding (called prophylaxis) or on demand when bleeding occurs.

How often you need infusions depends on the severity of your hemophilia, how your body metabolizes the factor, and your lifestyle. Someone with severe hemophilia might infuse two to three times per week as prevention. Someone with mild hemophilia might only need factor when injured or before surgery.

Key Takeaways

  • Factor replacement therapy—infusing clotting factor VIII or IX—is the standard treatment and can be given on a schedule to prevent bleeding or when bleeding occurs.
  • Newer treatments like emicizumab (Hemlibra) and gene therapy work differently than factor replacement and may reduce infusion frequency or eliminate it entirely.
  • Prophylaxis (preventive infusions on a regular schedule) reduces joint damage and bleeding episodes far more than treating bleeding only after it happens.
  • Your hemophilia treatment team includes your hematologist, a hemophilia nurse, and often a physical therapist and orthopedic specialist.
  • Home infusion training lets most people with hemophilia self-infuse or have a family member infuse, avoiding frequent clinic visits.

Prophylaxis Versus On-Demand Treatment

The choice between preventive and reactive treatment shapes your long-term health. Prophylaxis means infusing factor on a regular schedule—typically two to three times per week—whether or not you are bleeding. This approach keeps clotting factor levels high enough to prevent most spontaneous bleeding and to cushion the impact of injuries.

Research over the past 20 years has shown that people on prophylaxis have far fewer joint bleeds, less joint damage, and better quality of life than those treated only when bleeding occurs. The trade-off is more frequent infusions and more time managing the condition. Many people with severe hemophilia now start prophylaxis in childhood.

On-demand treatment means infusing factor only when bleeding starts or before a planned procedure. This requires fewer infusions but leaves you vulnerable to spontaneous bleeding into joints and muscles. Over time, repeated bleeds can cause permanent joint damage, chronic pain, and loss of movement. On-demand treatment is more common in mild hemophilia, where spontaneous bleeding is rare.

Newer Treatments Beyond Factor Replacement

Emicizumab (brand name Hemlibra) is a monoclonal antibody that works around the missing clotting factor rather than replacing it. Instead of providing factor VIII or IX, emicizumab bridges the gap in the clotting cascade by connecting two other factors. It is given as an injection under the skin, usually once every two or four weeks depending on the dose. For people with hemophilia A, emicizumab can reduce or eliminate the need for factor VIII infusions.

Gene therapy is the newest approach and works by delivering a working copy of the hemophilia gene into your liver cells. Your liver then produces the clotting factor on its own. Two gene therapies have been approved by the FDA: eteplirsen (Hemgenix) for hemophilia B and valoctocogene roxaparvovec (Roctavian) for hemophilia A. A single infusion can produce lasting improvement, though long-term outcomes are still being tracked. Gene therapy is typically offered to adults with severe hemophilia who have no antibodies against the treatment.

These newer treatments do not work for everyone. Some people develop antibodies (inhibitors) that block factor replacement or emicizumab. Others may not be candidates for gene therapy due to liver disease or other factors. Your hematologist will discuss which options fit your situation.

Managing Inhibitors: When Your Body Blocks Treatment

About 30 percent of people with hemophilia A and 5 percent with hemophilia B develop inhibitors—antibodies that attack the clotting factor you infuse. When this happens, factor replacement stops working, and you need different treatment.

The first step is inhibitor bypass therapy, which uses agents that skip over the blocked factor and restart clotting downstream. Activated prothrombin complex concentrate (aPCC, brand name FEIBA) and recombinant factor VIIa (NovoSeven) are the main options. These work but are less predictable than factor replacement and carry higher clot risk.

The second step is immune tolerance induction (ITI), a process where you infuse large doses of factor repeatedly over weeks or months to train your immune system to stop attacking it. ITI works in about 70 percent of cases but is intensive and expensive. Emicizumab has also become an option for people with inhibitors, since it works through a different mechanism.

Home Infusion and Self-Management

Most people with hemophilia learn to infuse themselves or have a family member trained to infuse at home. This avoids repeated trips to the clinic and gives you control over your treatment schedule. Training typically takes a few sessions with a hemophilia nurse, who teaches you how to find a vein, prepare the factor, and infuse safely.

Home infusion requires keeping factor refrigerated (or at room temperature, depending on the product), maintaining sterile technique, and tracking your infusions in a log. You will also need supplies: needles, alcohol wipes, gauze, and a sharps container. Your hemophilia center provides these or tells you where to order them.

Some people use a port—a small device surgically placed under the skin that connects to a vein—to avoid repeated needle sticks. Ports reduce vein damage and make infusion easier, though they require occasional flushing and carry a small infection risk.

Treatment Before and After Surgery

Any surgery—including dental work—requires careful planning if you have hemophilia. Your surgeon and hematologist must coordinate to ensure your clotting factor is high enough before, during, and after the procedure.

For minor procedures like tooth extraction, you may need a single high-dose infusion beforehand and possibly one or two afterward. For major surgery, you typically infuse before the procedure and then on a schedule for days or weeks after, depending on how quickly the surgical site heals. Some surgeons ask for factor levels to be checked during recovery to confirm they are adequate.

Certain surgeries—like joint replacement for someone with severe joint damage from hemophilia—require especially close coordination because the surgery itself is complex and bleeding risk is high. Your hemophilia center will work with the surgical team to create a detailed plan.

Living Well With Hemophilia Treatment

Beyond infusions, managing hemophilia means protecting your joints and muscles. Physical therapy helps maintain strength and range of motion, especially if you have had bleeds. Low-impact exercise like swimming and walking is safer than contact sports or activities with high fall risk.

Dental care matters too. Good oral hygiene prevents infections that could lead to bleeding, and your dentist should know you have hemophilia before any procedure. Certain medications—especially aspirin and other nonsteroidal anti-inflammatory drugs—can worsen bleeding and should be avoided unless your hematologist approves them.

Your hemophilia team typically includes your hematologist, a hemophilia nurse coordinator, a physical therapist, and sometimes an orthopedic specialist or social worker. Regular clinic visits let your team monitor your joint health, adjust your treatment plan, and catch problems early. Many hemophilia centers also offer support groups and educational resources.

Frequently Asked Questions

How long does factor replacement last in your body?

Factor VIII typically lasts 8 to 12 hours, so people with hemophilia A on prophylaxis usually infuse two to three times per week. Factor IX lasts longer—18 to 24 hours—so people with hemophilia B may infuse twice weekly. Individual variation is common, and your hematologist can measure your factor levels to determine the best schedule for you.

Can hemophilia be cured?

Gene therapy offers the possibility of a lasting cure by enabling your liver to produce clotting factor on its own. However, it is relatively new, and long-term outcomes are still being studied. Factor replacement and emicizumab manage hemophilia effectively but do not cure it—you continue treatment indefinitely.

What happens if you miss an infusion?

If you miss a prophylaxis infusion, your clotting factor levels drop, and your risk of spontaneous bleeding increases. Missing one infusion occasionally is usually not dangerous, but missing multiple infusions in a row raises your risk significantly. If you forget an infusion, contact your hemophilia center for guidance on whether to infuse late or wait for your next scheduled dose.

Do you need to travel with factor replacement?

Yes. If you travel, you need to bring enough factor for the entire trip plus extra in case of emergency. Factor must be kept at the right temperature—refrigerated for most products, room temperature for others. Airlines allow factor in carry-on bags if you have a letter from your hematologist. Your hemophilia center can help you plan travel logistics.

How much does hemophilia treatment cost?

Factor replacement and newer treatments are expensive—annual costs can range from tens of thousands to hundreds of thousands of dollars depending on the treatment and severity. Most insurance plans cover hemophilia treatment, and programs like the Hemophilia Health Services (HHS) program help uninsured and underinsured people access factor. Your hemophilia center social worker can connect you with financial resources.